Cargando…

JNK pathway is involved in the inhibition of inflammatory target gene expression and NF-kappaB activation by melittin

BACKGROUND: Bee venom therapy has been used to treat inflammatory diseases including rheumatoid arthritis in humans and in experimental animals. We previously found that bee venom and melittin (a major component of bee venom) have anti-inflammatory effect by reacting with the sulfhydryl group of p50...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Hye Ji, Lee, Hwa Jeong, Choi, Myung Sook, Son, Dong Ju, Song, Ho Sueb, Song, Min Jong, Lee, Jeong Min, Han, Sang Bae, Kim, Youngsoo, Hong, Jin Tae
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2442592/
https://www.ncbi.nlm.nih.gov/pubmed/18507870
http://dx.doi.org/10.1186/1476-9255-5-7
_version_ 1782156707002056704
author Park, Hye Ji
Lee, Hwa Jeong
Choi, Myung Sook
Son, Dong Ju
Song, Ho Sueb
Song, Min Jong
Lee, Jeong Min
Han, Sang Bae
Kim, Youngsoo
Hong, Jin Tae
author_facet Park, Hye Ji
Lee, Hwa Jeong
Choi, Myung Sook
Son, Dong Ju
Song, Ho Sueb
Song, Min Jong
Lee, Jeong Min
Han, Sang Bae
Kim, Youngsoo
Hong, Jin Tae
author_sort Park, Hye Ji
collection PubMed
description BACKGROUND: Bee venom therapy has been used to treat inflammatory diseases including rheumatoid arthritis in humans and in experimental animals. We previously found that bee venom and melittin (a major component of bee venom) have anti-inflammatory effect by reacting with the sulfhydryl group of p50 of nuclear factor-kappa B (NF-κB) and IκB kinases (IKKs). Since mitogen activated protein (MAP) kinase family is implicated in the NF-κB activation and inflammatory reaction, we further investigated whether activation of MAP kinase may be also involved in the anti-inflammatory effect of melittin and bee venom. METHODS: The anti-inflammatory effects of melittin and bee venom were investigated in cultured Raw 264.7 cells, THP-1 human monocytic cells and Synoviocytes. The activation of NF-κB was investigated by electrophoretic mobility shift assay. Nitric oxide (NO) and prostaglandin E(2 )(PGE(2)) were determined either by Enzyme Linked Immuno Sorbent Assay or by biochemical assay. Expression of IκB, p50, p65, inducible nitric oxide synthetase (iNOS), cyclooxygenase-2 (COX-2) as well as phosphorylation of MAP kinase family was determined by Western blot. RESULTS: Melittin (0.5–5 μg/ml) and bee venom (5 and 10 μg/ml) inhibited lipopolysaccharide (LPS, 1 μg/ml) and sodium nitroprusside (SNP, 200 μM)-induced activation of c-Jun NH2-terminal kinase (JNK) in RAW 264.7 cells in a dose dependent manner. However, JNK inhibitor, anthra [1,9-cd]pyrazole-6 (2H)-one (SP600215, 10–50 μM) dose dependently suppressed the inhibitory effects of melittin and bee venom on NF-κB dependent luciferase and DNA binding activity via suppression of the inhibitory effect of melittin and bee venom on the LPS and SNP-induced translocation of p65 and p50 into nucleus as well as cytosolic release of IκB. Moreover, JNK inhibitor suppressed the inhibitory effects of melittin and bee venom on iNOS and COX-2 expression, and on NO and PGE(2 )generation. CONCLUSION: These data show that melittin and bee venom prevent LPS and SNP-induced NO and PGE(2 )production via JNK pathway dependent inactivation of NF-κB, and suggest that inactivation of JNK pathways may also contribute to the anti-inflammatory and anti-arthritis effects of melittin and bee venom.
format Text
id pubmed-2442592
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-24425922008-07-02 JNK pathway is involved in the inhibition of inflammatory target gene expression and NF-kappaB activation by melittin Park, Hye Ji Lee, Hwa Jeong Choi, Myung Sook Son, Dong Ju Song, Ho Sueb Song, Min Jong Lee, Jeong Min Han, Sang Bae Kim, Youngsoo Hong, Jin Tae J Inflamm (Lond) Research BACKGROUND: Bee venom therapy has been used to treat inflammatory diseases including rheumatoid arthritis in humans and in experimental animals. We previously found that bee venom and melittin (a major component of bee venom) have anti-inflammatory effect by reacting with the sulfhydryl group of p50 of nuclear factor-kappa B (NF-κB) and IκB kinases (IKKs). Since mitogen activated protein (MAP) kinase family is implicated in the NF-κB activation and inflammatory reaction, we further investigated whether activation of MAP kinase may be also involved in the anti-inflammatory effect of melittin and bee venom. METHODS: The anti-inflammatory effects of melittin and bee venom were investigated in cultured Raw 264.7 cells, THP-1 human monocytic cells and Synoviocytes. The activation of NF-κB was investigated by electrophoretic mobility shift assay. Nitric oxide (NO) and prostaglandin E(2 )(PGE(2)) were determined either by Enzyme Linked Immuno Sorbent Assay or by biochemical assay. Expression of IκB, p50, p65, inducible nitric oxide synthetase (iNOS), cyclooxygenase-2 (COX-2) as well as phosphorylation of MAP kinase family was determined by Western blot. RESULTS: Melittin (0.5–5 μg/ml) and bee venom (5 and 10 μg/ml) inhibited lipopolysaccharide (LPS, 1 μg/ml) and sodium nitroprusside (SNP, 200 μM)-induced activation of c-Jun NH2-terminal kinase (JNK) in RAW 264.7 cells in a dose dependent manner. However, JNK inhibitor, anthra [1,9-cd]pyrazole-6 (2H)-one (SP600215, 10–50 μM) dose dependently suppressed the inhibitory effects of melittin and bee venom on NF-κB dependent luciferase and DNA binding activity via suppression of the inhibitory effect of melittin and bee venom on the LPS and SNP-induced translocation of p65 and p50 into nucleus as well as cytosolic release of IκB. Moreover, JNK inhibitor suppressed the inhibitory effects of melittin and bee venom on iNOS and COX-2 expression, and on NO and PGE(2 )generation. CONCLUSION: These data show that melittin and bee venom prevent LPS and SNP-induced NO and PGE(2 )production via JNK pathway dependent inactivation of NF-κB, and suggest that inactivation of JNK pathways may also contribute to the anti-inflammatory and anti-arthritis effects of melittin and bee venom. BioMed Central 2008-05-29 /pmc/articles/PMC2442592/ /pubmed/18507870 http://dx.doi.org/10.1186/1476-9255-5-7 Text en Copyright © 2008 Park et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Park, Hye Ji
Lee, Hwa Jeong
Choi, Myung Sook
Son, Dong Ju
Song, Ho Sueb
Song, Min Jong
Lee, Jeong Min
Han, Sang Bae
Kim, Youngsoo
Hong, Jin Tae
JNK pathway is involved in the inhibition of inflammatory target gene expression and NF-kappaB activation by melittin
title JNK pathway is involved in the inhibition of inflammatory target gene expression and NF-kappaB activation by melittin
title_full JNK pathway is involved in the inhibition of inflammatory target gene expression and NF-kappaB activation by melittin
title_fullStr JNK pathway is involved in the inhibition of inflammatory target gene expression and NF-kappaB activation by melittin
title_full_unstemmed JNK pathway is involved in the inhibition of inflammatory target gene expression and NF-kappaB activation by melittin
title_short JNK pathway is involved in the inhibition of inflammatory target gene expression and NF-kappaB activation by melittin
title_sort jnk pathway is involved in the inhibition of inflammatory target gene expression and nf-kappab activation by melittin
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2442592/
https://www.ncbi.nlm.nih.gov/pubmed/18507870
http://dx.doi.org/10.1186/1476-9255-5-7
work_keys_str_mv AT parkhyeji jnkpathwayisinvolvedintheinhibitionofinflammatorytargetgeneexpressionandnfkappabactivationbymelittin
AT leehwajeong jnkpathwayisinvolvedintheinhibitionofinflammatorytargetgeneexpressionandnfkappabactivationbymelittin
AT choimyungsook jnkpathwayisinvolvedintheinhibitionofinflammatorytargetgeneexpressionandnfkappabactivationbymelittin
AT sondongju jnkpathwayisinvolvedintheinhibitionofinflammatorytargetgeneexpressionandnfkappabactivationbymelittin
AT songhosueb jnkpathwayisinvolvedintheinhibitionofinflammatorytargetgeneexpressionandnfkappabactivationbymelittin
AT songminjong jnkpathwayisinvolvedintheinhibitionofinflammatorytargetgeneexpressionandnfkappabactivationbymelittin
AT leejeongmin jnkpathwayisinvolvedintheinhibitionofinflammatorytargetgeneexpressionandnfkappabactivationbymelittin
AT hansangbae jnkpathwayisinvolvedintheinhibitionofinflammatorytargetgeneexpressionandnfkappabactivationbymelittin
AT kimyoungsoo jnkpathwayisinvolvedintheinhibitionofinflammatorytargetgeneexpressionandnfkappabactivationbymelittin
AT hongjintae jnkpathwayisinvolvedintheinhibitionofinflammatorytargetgeneexpressionandnfkappabactivationbymelittin